表紙
市場調査レポート

中国のPTCAバルーンカテーテル市場 (2015-2019年)

PTCA Balloon Catheter Market in China 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 336540
出版日 ページ情報 英文 106 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
中国のPTCAバルーンカテーテル市場 (2015-2019年) PTCA Balloon Catheter Market in China 2015-2019
出版日: 2015年07月29日 ページ情報: 英文 106 Pages
概要

PTCAは、心筋への血液の流れを遮らないように、冠動脈における障害物の除去に利用される低侵襲手順です。この手順においては、プラークによる動脈の閉塞を圧迫して除去し、詰まった冠動脈を拡張するために、PTCAバルーンカテーテルが設置されます。PTCAバルーンカテーテルは、先端に拡張可能なバルーンを備えた柔らかいデバイスであり、カテーテル処置に際して動脈に挿入されます。そしてそのバルーンを膨らませて閉塞を除去し、動脈を拡張します。PTCAバルーンカテーテルは、インターベンショナル (介入性) 心臓病学の分野において最初に使われたものの1つです。Technavioのアナリストは、中国のPTCAバルーンカテーテル市場が2014年から2019年にかけてCAGR (複合年間成長率) 14.75%で成長すると予測しています。

当レポートでは、中国のPTCAバルーンカテーテル市場を取り上げ、市場の概要、市場発展促進要因、市場における課題、ならびにそれらの影響を概括し、製品タイプ別に市場の現状と見通しについて調査分析するとともに、主なベンダーの分析をまとめています。

第1章 エグゼクティブサマリー

第2章 略語集

第3章 調査範囲

  • 市場概要
  • 提供製品

第4章 市場調査手法

  • 市場調査の過程
  • 調査手法

第5章 イントロダクション

第6章 PTCA:概要

  • PTCAについて
    • 背景
    • 定義
    • PTCAに関わる手順
    • PTCAの利点
    • PTCAに関連した合併症とリスク
    • PTCAバルーンカテーテル罹患者
  • PTCAバルーンカテーテルの素材
    • カテーテル蔬菜の比較
  • カテーテル法の合併症
    • 背景
    • 合併症の原因

第7章 市場情勢

  • 市場概要
  • 市場規模・予測
  • ファイブフォース分析

第8章 市場区分、製品タイプ別

  • 通常のバルーンカテーテル
  • 薬剤溶出バルーンカテーテル
  • カッティングバルーンカテーテル
  • スコアリングバルーンカテーテル

第9章 中国における医療改革

  • 医療改革
    • 医療アクセスに対する保険のカバレッジ
    • 医療インフラの改善

第10章 国際的ベンダーおよび現地ベンダーの市場機会

  • 現地ベンダー
    • 現地ベンダーの課題
  • 国際的ベンダー
    • 国際的ベンダーの課題

第11章 購入条件

第12章 市場成長促進要因

第13章 促進要因とその影響

第14章 市場における課題

第15章 促進要因と課題の影響

第16章 市場動向

第17章 動向とその影響

第18章 ベンダー情勢

  • 競合シナリオ
    • 主なニュース
    • 吸収・合併
  • 市場シェア分析、2014年
    • Abbott Laboratories
    • Boston Scientific
    • Medtronic
    • MicroPort Scientific
    • テルモ
  • その他の主なベンダー

第19章 主なベンダーの分析 (主な情報、事業説明、主要製品、事業区分、事業戦略、事業区分別売上、地域別売上、最近の動向、SWOT分析)

  • Abbott Laboratories
  • Boston Scientific
  • Medtronic
  • MicroPort Scientific
  • テルモ

第20章 本シリーズにおける他のレポート

図表リスト

目次
Product Code: IRTNTR6811

About PTCA balloon catheter

PTCA is a minimally invasive procedure used to remove the blockage of coronary arteries, permitting uninterrupted blood flow to the heart muscle. The procedure involves the placement of a PTCA balloon catheter to compress and clear the blockage caused by plaques and to widen the clogged coronary artery. A PTCA balloon catheter is a soft device equipped with a small inflatable balloon at its tip, which is inserted into an artery during the catheterization procedure. The balloon is then bloated to clear the blockage and widen the artery. PTCA balloon catheter was the first of its kind used in the field of interventional cardiology. It is also used to position stents during angioplasty.

Technavio's analysts forecast the PTCA balloon catheter market in China to grow at a CAGR of 14.75% over the period 2014-2019.

Covered in this report

The report includes the present scenario and the growth prospects of the PTCA balloon catheter market in China for the period 2015-2019. To calculate the market size, Technavio uses revenue generated from the sales of PTCA balloon catheters.

Technavio's report, PTCA Balloon Catheter Market in China 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott Laboratories
  • Boston Scientific
  • Medtronic
  • MicroPort Scientific
  • Terumo

Other Prominent Vendors

  • Aachen Resonance
  • Acrostak
  • AngioScore
  • Alvimedica
  • Asahi Intecc
  • Arthesys
  • Atrium Medical
  • B. Braun Melsungen
  • Biosensors International
  • BIOTRONIK
  • Cordis
  • Cook Medical
  • C.R. Bard
  • Goodman
  • Lepu Medical
  • Natec Medical
  • Smiths Medical
  • Tokai Medical Products
  • Volcano

Market driver

  • Growing geriatric population
  • For a full, detailed list, view our report

Market challenge

  • Alternative therapies
  • For a full, detailed list, view our report

Market trend

  • High demand for minimally invasive procedures
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. PTCA: An Overview

  • 06.1. About PTCA
    • 06.1.1. Background
    • 06.1.2. Definition
    • 06.1.3. Steps Involved in PTCA
    • 06.1.4. Advantages of PTCA
    • 06.1.5. Complications and Risks Involved in PTCA
    • 06.1.6. PTCA Balloon Catheters Affected Individuals
  • 06.2. PTCA Balloon Catheter Materials
    • 06.2.1. Comparison of Catheter Materials
  • 06.3. Complications of Catheterization
    • 06.3.1. Background
    • 06.3.2. Causes of Complications

07. Market Landscape

  • 07.1. Market Overview
  • 07.2. Market Size and Forecast
  • 07.3. Five Forces Analysis

08. Market Segmentation by Product Type

  • 08.1. Normal Balloon Catheter
  • 08.2. Drug-Eluting Balloon Catheter
  • 08.3. Cutting Balloon Catheter
  • 08.4. Scoring Balloon Catheter

09. Healthcare Reform in China

  • 09.1. Healthcare Reforms
    • 09.1.1. Insurance Coverage for Healthcare Access
    • 09.1.2. Improvement in Healthcare Infrastructure

10. Opportunities for Global and Local Vendors

  • 10.1. Local Vendors
    • 10.1.1. Challenges for Local Vendors
  • 10.2. Global Vendors
    • 10.2.1. Challenges for Global Vendors

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and Their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and Their Impact

18. Vendor Landscape

  • 18.1. Competitive Scenario
    • 18.1.1. Key News
    • 18.1.2. Mergers and Acquisitions
  • 18.2. Market Share Analysis 2014
    • 18.2.1. Abbott Laboratories
    • 18.2.2. Boston Scientific
    • 18.2.3. Medtronic
    • 18.2.4. MicroPort Scientific
    • 18.2.5. Terumo
  • 18.3. Other Prominent Vendors

19. Key Vendor Analysis

  • 19.1. Abbott Laboratories
    • 19.1.1. Key Facts
    • 19.1.2. Business Description
    • 19.1.3. Business Segmentation
    • 19.1.4. Business Strategy
    • 19.1.5. Revenue by Business Segmentation
    • 19.1.6. Revenue Comparison 2011 and 2012
    • 19.1.7. Revenue by Geographical Segmentation
    • 19.1.8. Key Information
    • 19.1.9. SWOT Analysis
  • 19.2. Boston Scientific
    • 19.2.1. Key Facts
    • 19.2.2. Business Overview
    • 19.2.3. Key Products
    • 19.2.4. Key Products in Cardiovascular Segment
    • 19.2.5. Key Products in MedSurg Segment
    • 19.2.6. Key Products in Rhythm Management Segment
    • 19.2.7. Business Segmentation by Revenue 2013
    • 19.2.8. Business Segmentation by Revenue 2012 and 2013
    • 19.2.9. Geographical Segmentation by Revenue 2013
    • 19.2.10. Business Strategy
    • 19.2.11. Recent Developments
    • 19.2.12. SWOT Analysis
  • 19.3. Medtronic
    • 19.3.1. Key Facts
    • 19.3.2. Business Overview
    • 19.3.3. Key Products
    • 19.3.4. Business Segmentation by Revenue 2014
    • 19.3.5. Cardiac and Vascular Group Segmentation by Revenue 2014
    • 19.3.6. Restorative Therapies Group Segmentation by Revenue 2014
    • 19.3.7. Diabetes Group Segmentation by Revenue 2014
    • 19.3.8. Business Segmentation by Revenue 2013 and 2014
    • 19.3.9. Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014
    • 19.3.10. Restorative Therapies Group Segmentation by Revenue 2013 and 2014
    • 19.3.11. Diabetes Group Segmentation by Revenue 2013 and 2014
    • 19.3.12. Geographical Segmentation by Revenue 2014
    • 19.3.13. Business Strategy
    • 19.3.14. Key Developments
    • 19.3.15. SWOT Analysis
  • 19.4. MicroPort Scientific
    • 19.4.1. Key Facts
    • 19.4.2. Business Overview
    • 19.4.3. Business Segmentation by Revenue 2013
    • 19.4.4. Business Segmentation by Revenue 2012 and 2013
    • 19.4.5. Geographical Segmentation by Revenue 2013
    • 19.4.6. Business Strategy
    • 19.4.7. Recent Developments
    • 19.4.8. SWOT Analysis
  • 19.5. Terumo
    • 19.5.1. Key Facts
    • 19.5.2. Business Overview
    • 19.5.3. Business Segmentation
    • 19.5.4. Revenue Segmentation by Business
    • 19.5.5. Business Segment Revenue Comparison - FY2011 and FY2012
    • 19.5.6. Revenue Segmentation by Geography
    • 19.5.7. Business Strategy
    • 19.5.8. Key Developments
    • 19.5.9. SWOT Analysis

20. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Various Steps of PTCA
  • Exhibit 3: PTCA Balloon Catheter Materials
  • Exhibit 4: Common HAIs in Acute Care Settings
  • Exhibit 5: Major PTCA Balloon Catheter Complications
  • Exhibit 2: PTCA Balloon Catheter Market in China 2014-2019 ($ millions)
  • Exhibit 6: Segmentation of PTCA Balloon Catheter Market in China by Product Type
  • Exhibit 7: Segmentation of PTCA Balloon Catheter Market in China by Product Type 2014
  • Exhibit 8: Disease Mortality in China 2012
  • Exhibit 9: Healthcare Reforms in China
  • Exhibit 10: Number of Medical Institutes in China until 2012
  • Exhibit 11: Various Establishments of Top Global Medical Device Companies in China
  • Exhibit 12: Elderly Population in China 1950-2050
  • Exhibit 13: Healthcare Expenditure in China 2005-2014
  • Exhibit 14: Abbott Laboratories: Key Takeaways
  • Exhibit 15: Boston Scientific: Key Takeaways
  • Exhibit 16: Medtronic: Key Takeaways
  • Exhibit 17: MicroPort Scientific: Key Takeaways
  • Exhibit 18: Terumo: Key Takeaways
  • Exhibit 19: Abbott Laboratories: Business Segmentation
  • Exhibit 20: Abbott Laboratories: Revenue by Business Segmentation 2012
  • Exhibit 21: Abbott Laboratories: Revenue by Business Segmentation 2011 and 2012 ($ millions)
  • Exhibit 22: Abbott Laboratories: Revenue by Geographical Segmentation 2012
  • Exhibit 23: Boston Scientific: Key Products in Cardiovascular Segment
  • Exhibit 24: Boston Scientific: Key Products in MedSurg Segment
  • Exhibit 25: Boston Scientific: Key Products in Rhythm Management Segment
  • Exhibit 26: Boston Scientific: Business Segmentation by Revenue 2013
  • Exhibit 27: Boston Scientific: Business Segmentation by Revenue 2012 and 2013 ($ millions)
  • Exhibit 28: Boston Scientific: Geographical Segmentation by Revenue 2013
  • Exhibit 29: Medtronic: Key Products
  • Exhibit 30: Medtronic: Business Segmentation by Revenue 2014
  • Exhibit 31: Medtronic: Cardiac and Vascular Group Segmentation by Revenue 2014
  • Exhibit 32: Medtronic: Restorative Therapies Group Segmentation by Revenue 2014
  • Exhibit 33: Medtronic: Diabetes Group Segmentation by Revenue 2014
  • Exhibit 34: Medtronic: Business Segmentation by Revenue 2013 and 2014 ($ millions)
  • Exhibit 35: Medtronic: Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014 ($ millions)
  • Exhibit 36: Medtronic: Restorative Therapies Group Segmentation by Revenue 2013 and 2014 ($ millions)
  • Exhibit 37: Medtronic: Diabetes Group Segmentation by Revenue 2013 and 2014 ($ millions)
  • Exhibit 38: Medtronic: Geographical Segmentation by Revenue 2014
  • Exhibit 39: MicroPort Scientific: Business Segmentation by Revenue 2013
  • Exhibit 40: MicroPort Scientific: Business Segmentation by Revenue 2012 and 2013 ($ millions)
  • Exhibit 41: MicroPort Scientific: Geographical Segmentation by Revenue 2013
  • Exhibit 42: Business Segmentation of Terumo
  • Exhibit 43: Revenue Segmentation of Terumo
  • Exhibit 44: Revenue Comparison of Business Segments ($ billions)
  • Exhibit 45: Revenue Segmentation by Geography FY2012
Back to Top